Skip to content

Clinical trials

Phase 2 Ischemic Attack, Transient trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Attack, Transient Phase: Phase 2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20082
20091
20111
20121
20131
20141
20151
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Alberta2
AdvanceCor GmbH1
Asan Medical Center1
Astellas Pharma Inc1
AtriCure, Inc.1
Bristol-Myers Squibb1
Marilyn MacKay-Lyons1
National Institute of Neurological Disorders and Stroke (NINDS)1
Orion Corporation, Orion Pharma1
University College Dublin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Attack, Transient12
Stroke7
Ischemic Stroke3
Atrial Fibrillation2
Amaurosis Fugax1
Atherosclerosis1
Camurati-Engelmann Syndrome1
Carotid Stenosis1
Hypertension1
Myocardial Infarction1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.